María Villa-Morales

12PUBLICATIONS
33CO-AUTHORS
Haematological tumoursPredictive and prognostic markersMolecular targetsSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 20, 2024
PIM1 is a potential therapeutic target for the leukemogenic effects mediated by JAK/STAT pathway mutations in T-ALL/LBL.

Antonio Lahera, Laura Vela-Martín, Pablo Fernández-Navarro

|Sep 15, 2023
The JAK3Q988P mutation reveals oncogenic potential and resistance to ruxolitinib.

Antonio Lahera, Laura Vela-Martín, Pablo Fernández-Navarro

|Jun 28, 2023
Identification of NRF2 Activation as a Prognostic Biomarker in T-Cell Acute Lymphoblastic Leukaemia.

María Villa-Morales, Laura Pérez-Gómez, Eduardo Pérez-Gómez

|May 30, 2023
Identification of fatty acid amide hydrolase as a metastasis suppressor in breast cancer.

Isabel Tundidor, Marta Seijo-Vila, Sandra Blasco-Benito

|Feb 14, 2023
SOCS3 deregulation contributes to aberrant activation of the JAK/STAT pathway in precursor T-cell neoplasms.

Antonio Lahera, Pilar López-Nieva, Hernán Alarcón

Pageof 2